Article
Acoziborole resistance associated mutations in trypanosome CPSF3
2025-11-27
Abstract excerpt
Acoziborole is a safe, single dose, oral therapy, for treatment of both early and late-stage sleeping sickness, a deadly disease caused by African trypanosomes. Other benzoxaboroles show efficacy against other trypanosomatids, apicomplexans, fungi, bacteria, and viruses. Acoziborole targets the trypanosome pre-mRNA processing endonuclease, cleavage and polyadenylation specificity factor 3 (CPSF3), and triggers CPS...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 31b67504-021e-539f-b159-ed833084eff1
- DOI
- 10.1101/2025.11.26.690711
